Norway Plasmid Dna Manufacturing Market Size & Outlook

The plasmid dna manufacturing market in Norway is expected to reach a projected revenue of US$ 38.0 million by 2030. A compound annual growth rate of 16.5% is expected of Norway plasmid dna manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$13.0
Forecast, 2030 (US$M)
$38.0
CAGR, 2024 - 2030
16.6%
Report Coverage
Norway

Norway plasmid dna manufacturing market, 2018-2030 (US$M)

Norway

Norway plasmid dna manufacturing market highlights

  • The Norway plasmid dna manufacturing market generated a revenue of USD 13.0 million in 2023 and is expected to reach USD 38.0 million by 2030.
  • The Norway market is expected to grow at a CAGR of 16.5% from 2024 to 2030.
  • In terms of segment, gmp grade was the largest revenue generating grade in 2023.
  • GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.


Plasmid dna manufacturing market data book summary

Market revenue in 2023USD 13.0 million
Market revenue in 2030USD 38.0 million
Growth rate16.5% (CAGR from 2023 to 2030)
Largest segmentGmp grade
Fastest growing segmentGMP Grade
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationR&D Grade, GMP Grade
Key market players worldwideCharles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI


Other key industry trends

  • In terms of revenue, Norway accounted for 0.7% of the global plasmid dna manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 243.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Plasmid DNA Manufacturing Market Companies

Name Profile # Employees HQ Website

Norway plasmid dna manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.


Gmp grade was the largest segment with a revenue share of 86.15% in 2023. Horizon Databook has segmented the Norway plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Norway plasmid dna manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway plasmid dna manufacturing market databook

  • Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway plasmid dna manufacturing market size, by grade, 2018-2030 (US$M)

Norway Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Norway plasmid dna manufacturing market size, by grade, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more